Jack Nielsen, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 20,939 shares at $50.25 ($1.1M) on 2022-04-07, disclosed to the SEC on 2022-04-11.
Open-market sale of $1.1M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.25 | 656 | $33K | 3.1% |
| 2 | $50.25 | 4,610 | $232K | 22.1% |
| 3 | $50.25 | 4,610 | $232K | 22.1% |
| 4 | $50.09 | 735 | $37K | 3.5% |
| 5 | $50.09 | 5,164 | $259K | 24.6% |
| 6 | $50.09 | 5,164 |
| $259K |
| 24.6% |
| Total | $50.17 avg | 20,939 | $1.1M | 100% |
| Filing → |
| HRMY | SELL | 2022-12-01 | $11.4M | — | Filing → |
| HRMY | SELL | 2022-11-22 | $7.7M | — | Filing → |
| HRMY | SELL | 2022-11-15 | $16.1M | — | Filing → |